July 25, 2011 -- Hutchison China MediTech will expand its business plan by adding third-party OTC drug distribution to its activities. The company announced a JV that will distribute its own TCM drugs and offer similar services to other companies. Chi-Med, as the company is popularly known, expects the new venture will add “substantially” to its profits. Previously, Chi-Med was allowed to distribute its own products, but not those of other companies. More details....
Stock Symbol: (AIM: HTM)
